CIK 0001770787
- Large accelerated filer
10x Genomics, Inc.
Sign in to watch- Ticker
- TXG
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455614458
- Phone
- +1 925-401-7300
- Business address
- 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
- 4 Grant or award Director acquired 2,120 shares (grant or award)
- 4 Grant or award Director acquired 2,120 shares (grant or award)
- 4 Gift Chief Executive Officer gave 1,651 shares (gift)
- 4 Open-market sale Chief Executive Officer sold 2,656 shares at $48.76 ($129,516)
- 4 Open-market sale Chief Financial Officer sold 967 shares at $48.76 ($47,155)
- 4 Open-market sale Hindson Benjamin J. sold 1,264 shares at $48.76 ($61,637)
- 4 Open-market sale Chief Commercial Officer sold 286 shares at $48.76 ($13,947)
- 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
- 4 Open-market buy Chief Financial Officer bought 158 shares at $40.49 ($6,397)
- 4 Open-market buy Chief Commercial Officer bought 158 shares at $40.49 ($6,397)
- 4 Grant or award Hindson Benjamin J. acquired 28,476 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 21,357 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 58,731 shares (grant or award)
- 4 Open-market sale Hindson Benjamin J. sold 360 shares at $78.59 ($28,294)
- 4 Open-market sale Chief Executive Officer sold 551 shares at $78.60 ($43,309)
- 4 Open-market sale Chief Financial Officer sold 288 shares at $78.60 ($22,637)
- 4 Open-market sale Chief Commercial Officer sold 288 shares at $78.60 ($22,637)
- 4 Open-market sale Chief Commercial Officer sold 17,000 shares at $95.13 ($1,617,261)
- 4 Open-market sale Chief Executive Officer sold 12,000 shares at an average $89.90 ($1,078,786)
- 4 Open-market sale Chief Commercial Officer sold 17,000 shares at an average $119.00 ($2,023,019)
Page 9 of 21 · 410 filings